Immunovia AB Share Price
Stocks
IMMNOV
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
17:00:00 14/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1570 SEK | +9.94% |
|
+21.14% | -30.84% |
| 09-03 | Six stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-01 | 17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Market Cap | 106M 10.83M 9.37M 8.85M 8.02M 15.06M 1.03B 15.17M 40.67M 527M 40.68M 39.78M 1.68B | P/E 2026 * |
-1.57x | P/E 2027 * | -3.93x |
|---|---|---|---|---|---|
| Enterprise Value | 70.61M 7.24M 6.27M 5.92M 5.36M 10.07M 692M 10.15M 27.19M 352M 27.2M 26.6M 1.13B | EV / Sales 2026 * |
22.1x | EV / Sales 2027 * | 4.37x |
| Free-Float |
90.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMMNOV | Delayed | |
CBOE
| IMMNOs | Real-time | |
|
OTC Markets
| IMMVF | Delayed | |
|
CBOE
| 0G8X | Real-time | |
|
Deutsche Boerse AG
| 1YR | Delayed | |
|
Boerse Muenchen
| 1YR | Real-time |
Last Transcript: Immunovia AB
| 1 day | +9.94% | ||
| 1 week | +21.14% | ||
| Current month | +11.51% | ||
| 1 month | -4.27% | ||
| 3 months | -12.58% | ||
| 6 months | -2.97% | ||
| Current year | -30.84% |
| 1 week | 0.14 |  | 0.17 |
| 1 month | 0.12 | | 0.18 |
| Current year | 0.12 | | 0.25 |
| 1 year | 0.12 | | 0.72 |
| 3 years | 0.12 | | 4.73 |
| 5 years | 0.12 | | 137.3 |
| 10 years | 0.12 | | 298.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 28/04/2023 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/04/2024 |
| Chief Tech/Sci/R&D Officer | 54 | 30/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 08/12/2016 | |
Peter Andersen
CHM | Chairman | 69 | 25/05/2023 |
| Director/Board Member | 51 | 31/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/11/22 | Buy | Chief Executive Officer | 150,000 | 0.6628% | ||
| 24/05/22 | Buy | Chief Executive Officer | 100,000 | 0.4419% | ||
| 21/05/22 | Buy | Chief Executive Officer | 100,000 | 0.4419% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.94% | +21.14% | -75.28% | -76.98% | 9.91M | |
| -2.15% | -3.92% | +18.24% | -31.56% | 16.73B | |
| +1.03% | +6.31% | -34.38% | +45.06% | 1.75B | |
| +0.41% | -3.89% | -28.07% | +25.51% | 893M | |
| -5.60% | -20.40% | -61.08% | -85.44% | 808M | |
| 0.00% | -0.27% | +63.36% | 0.00% | 778M | |
| +0.19% | -4.99% | -38.74% | -49.84% | 637M | |
| +1.76% | -8.00% | -42.32% | -51.29% | 560M | |
| -0.90% | -15.69% | -44.80% | -38.40% | 450M | |
| -0.25% | +0.37% | -8.00% | -2.54% | 397M | |
| Average | +0.44% | -3.90% | -25.11% | -26.55% | 2.3B | |
| Weighted average by Cap. | -1.63% | -2.59% | +6.40% | -24.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 328K 284K 268K 243K 456K 31.35M 460K 1.23M 15.96M 1.23M 1.21M 51.01M | 17.3M 1.77M 1.54M 1.45M 1.31M 2.47M 170M 2.49M 6.66M 86.29M 6.66M 6.52M 276M |
| Net income | -87M -8.92M -7.72M -7.29M -6.61M -12.4M -852M -12.5M -33.5M -434M -33.51M -32.77M -1.39B | -76M -7.79M -6.75M -6.37M -5.77M -10.84M -745M -10.92M -29.27M -379M -29.27M -28.63M -1.21B |
| Net Debt | -35M -3.59M -3.11M -2.93M -2.66M -4.99M -343M -5.03M -13.48M -175M -13.48M -13.18M -558M | -30M -3.08M -2.66M -2.51M -2.28M -4.28M -294M -4.31M -11.55M -150M -11.55M -11.3M -478M |
Employees
18
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | SEK 0.1570 | +9.94% | 5,778,235 |
| 11/09/26 | SEK 0.1428 | +0.56% | 2,202,786 |
| 10/09/26 | SEK 0.1420 | -4.18% | 1,955,787 |
| 09/09/26 | SEK 0.1482 | -1.20% | 3,009,698 |
| 08/09/26 | SEK 0.1500 | -10.50% | 7,740,306 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
Select your edition
All financial news and data tailored to specific country editions
